A carregar...
Cladribine modifies functional properties of microglia
Cladribine (CdA), an oral prodrug approved for the treatment of relapsing multiple sclerosis, selectively depletes lymphocytes. CdA passes the blood–brain barrier, suggesting a potential effect on central nervous system (CNS) resident cells. We examined if CdA modifies the phenotype and function of...
Na minha lista:
| Publicado no: | Clin Exp Immunol |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7419928/ https://ncbi.nlm.nih.gov/pubmed/32492189 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cei.13473 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|